uric acid has been researched along with Hyperprolactinemia in 4 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study included two age-, weight-, lipid-, and prolactin level-matched groups of premenopausal women with hypecholesterolemia and a history of hyperprolactinemia: patients treated with bromocriptine (5." | 9.20 | The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia. ( Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W, 2015) |
| " The aim of this study was to investigate whether autoimmune thyroiditis determines cardiometabolic effects of cabergoline." | 8.31 | Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia. ( Kowalcze, K; Krysiak, R; Okopień, B, 2023) |
| "The study included two age-, weight-, lipid-, and prolactin level-matched groups of premenopausal women with hypecholesterolemia and a history of hyperprolactinemia: patients treated with bromocriptine (5." | 5.20 | The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia. ( Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W, 2015) |
| " The aim of this study was to evaluate the effects of hyperprolactinemia and bromocriptine (Brc) treatment on endothelial function, insulin sensitivity and inflammatory markers in pre-menopausal women." | 5.10 | Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women. ( Akalin, S; Akpinar, I; Deyneli, O; Gözü, H; Haklar, G; Sezgin, O; Yavuz, D; Yildiz, E, 2003) |
| " The aim of this study was to investigate whether autoimmune thyroiditis determines cardiometabolic effects of cabergoline." | 4.31 | Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia. ( Kowalcze, K; Krysiak, R; Okopień, B, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krysiak, R | 3 |
| Kowalcze, K | 1 |
| Okopień, B | 3 |
| Basiak, M | 1 |
| Machnik, G | 1 |
| Szkróbka, W | 2 |
| Gilowski, W | 1 |
| Yavuz, D | 1 |
| Deyneli, O | 1 |
| Akpinar, I | 1 |
| Yildiz, E | 1 |
| Gözü, H | 1 |
| Sezgin, O | 1 |
| Haklar, G | 1 |
| Akalin, S | 1 |
2 trials available for uric acid and Hyperprolactinemia
| Article | Year |
|---|---|
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; D | 2015 |
Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women.
Topics: Adult; Blood Glucose; Bromocriptine; C-Reactive Protein; Cholesterol; Endothelium, Vascular; Estroge | 2003 |
2 other studies available for uric acid and Hyperprolactinemia
| Article | Year |
|---|---|
Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia.
Topics: C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Cholesterol; Creatinine; Female; Fibrinoge | 2023 |
Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study.
Topics: C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Female; Fibrinogen; Glucose; Humans; Hyper | 2023 |